SCHEMBL9094

SCHEMBL9094

COC(=O)C=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.50
POLB P06746 2/20 0.46
TSHR P16473 1/20 0.42
KMT2A Q03164 2/20 0.38
KCNN4 O15554 1/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
AKT1 P31749 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA5A P35218 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
NPC1 O15118 1/20 0.36
HCAR2 Q8TDS4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12305771 1.00 HSP90AA1 (0.50) HSP90AA1POLBTSHRKMT2AKCNN4
SCHEMBL12305754 1.00 HSP90AA1 (0.50) HSP90AA1POLBTSHRKMT2AKCNN4
SCHEMBL1162211 0.82 HSP90AA1 (0.43) HSP90AA1POLBTSHRKMT2ARAB9A
SCHEMBL13908046 0.81 HSP90AA1 (0.47) HSP90AA1POLBTSHRKMT2AALDH1A1
SCHEMBL5077963 0.80 HSP90AA1 (0.55) HSP90AA1KMT2ARAB9AALDH1A1MAPT
SCHEMBL360684 0.79 HSP90AA1 (0.46) HSP90AA1POLBTSHRKMT2ARAB9A
SCHEMBL13539121 0.79 HSP90AA1 (0.46) HSP90AA1POLBTSHRKMT2AKCNN4
SCHEMBL2392066 0.79 HSP90AA1 (0.46) HSP90AA1TSHRKMT2ARAB9AALDH1A1
SCHEMBL65066 0.79 HSP90AA1 (0.50) HSP90AA1POLBTSHRKMT2ARAB9A
SCHEMBL23594169 0.79 POLB (0.34) HSP90AA1POLBTSHRKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2297 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441759-B2 Method for synthesizing ursodeoxycholic acid using BA as raw material JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP., LTD. (CN) 2025-10-14 US claimed
CN-119812476-A Electrolyte, battery pack and electric equipment 比亚迪股份有限公司 2025-04-11 CN claimed
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US claimed
US-20240374769-A1 LIGHT ACTIVATED CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY 2024-11-14 US claimed
WO-2024233595-A1 LIGHT ACTIVATED CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2024-11-14 WO claimed
EP-4396271-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF Momentive Performance Materials Inc. (US) 2024-07-10 EP claimed
WO-2023034354-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2023-03-09 WO claimed
US-20230039886-A1 METHOD FOR SYNTHESIZING URSODEOXYCHOLIC ACID USING BA AS RAW MATERIAL JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP., LTD. (CN) 2023-02-09 US claimed
EP-3564243-B1 PRODUCTION INTERMEDIATE OF ERIBULIN MESYLATE, AND METHOD FOR PRODUCING SAME YONSUNG FINE CHEMICAL CO LTD (KR) 2022-11-09 EP claimed
CN-110139866-B Intermediate for preparing eribulin mesylate and method for preparing same 研成精密化学株式会社 2022-05-17 CN claimed
US-20190161425-A1 Novel Process for the Synthesis of Docosanol BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2019-05-30 US claimed
CN-104981519-A Ultra low cure powder coating VALSPAR SOURCING INC 2015-10-14 CN claimed
EP-1347981-B1 CONDENSED PURINE DERIVATIVES AS A 1 ADENOSINE RECEPTOR ANTAGONISTS BIOGEN IDEC INC (US) 2008-05-07 EP claimed
US-20030220358-A1 A1 adenosine receptro antagonists BIOGEN IDEC MA INC. 2003-11-27 US claimed
EP-1347981-A1 CONDENSED PURINE DERIVATIVES AS A 1? ADENOSINE RECEPTOR ANTAGONISTS BIOGEN, INC. (US) 2003-10-01 EP claimed
US-20020111333-A1 A1 adenosine receptor antagonists BIOGEN IDEC MA INC. 2002-08-15 US claimed
WO-2002044182-A1 CONDENSED PURINE DERIVATIVES AS A1 ADENOSINE RECEPTOR ANTAGONISTS BIOGEN, INC. (US) 2002-06-06 WO claimed
EP-0648741-B1 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivatives as antithrombotic agents ADIR (FR) 1996-12-18 EP claimed
WO-1995020585-A1 DIASTEREOSELECTIVE PROCESS LEADING TO A KEY INTERMEDIATE FOR THE PREPARATION OF FLUORINATED REVERSE TRANSCRIPTASE INHIBITORS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-08-03 WO claimed
EP-0648741-A1 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivatives as antithrombotic agents ADIR ET COMPAGNIE (FR) 1995-04-19 EP claimed